IHH Healthcare Cancels IPO Plans for Agilus Diagnostics in India
In a surprising move, IHH Healthcare, a prominent Malaysian hospital operator, along with its investors, has announced the withdrawal of its plans for an initial public offering (IPO) for Agilus Diagnostics in India. The decision, driven by "commercial considerations," marks a significant shift in IHH Healthcare's strategic direction in one of the world's largest healthcare markets.
Exclusive Access: Unlock Premium, Confidential Insights
Unlock This Exclusive Content—Subscribe Instantly!
Login if you have purchased
